Related Experiment Videos
Non-functioning pituitary adenomas: indications for postoperative radiotherapy.
A C Woollons1, M K Hunn, Y R Rajapakse
1Department of Neurosurgery, Wellington Hospital, Wellington, New Zealand. P.J.Jenkins@mds.qmw.ac.uk
Clinical Endocrinology
|January 13, 2001
Summary
Postoperative radiotherapy is recommended for patients with residual nonfunctioning pituitary macroadenoma after surgery. Complete tumor removal minimizes recurrence risk, making routine radiotherapy unnecessary in such cases.
Area of Science:
- Neurosurgery
- Endocrinology
- Radiation Oncology
Background:
- Nonfunctioning pituitary macroadenomas are common intracranial tumors.
- Surgical resection is the primary treatment, but recurrence is a concern.
- The role of adjuvant radiotherapy remains debated.
Purpose of the Study:
- To identify indications for postoperative radiotherapy after surgical resection of nonfunctioning pituitary macroadenoma.
- To evaluate the efficacy of radiotherapy in preventing tumor recurrence.
- To determine prognostic factors for recurrence.
Main Methods:
- Retrospective chart review of 72 patients with chromophobe adenoma.
- Minimum follow-up of 12 months, with a mean follow-up of 64 months.
- Proportional hazards model used to identify prognostic factors.
Main Results:
- Tumor recurrence was significantly lower in patients who received postoperative radiotherapy (26%) compared to those who did not (46%).
- In patients with residual tumor, radiotherapy reduced recurrence rates from 73% to 32%.
- Complete tumor excision was associated with a low recurrence rate (10%), even without radiotherapy.
Conclusions:
- Complete surgical excision should be the primary goal.
- Routine postoperative radiotherapy can be withheld in patients with no residual tumor.
- Postoperative radiotherapy is effective in reducing recurrence in patients with residual tumor.